EN PL
ORIGINAL PAPER
Mobility limitation of hip joints in people aged 50–70
 
More details
Hide details
 
Online publication date: 2010-12-20
 
 
Reumatologia 2010;48(6):366-371
 
KEYWORDS
ABSTRACT
Osteoarthritis of hip joints is usually diagnosed at advanced stages of the disease when degenerative changes are evident. We propose a simple and easy tool for screening of early stages of the disease with a few or no clinical symptoms. Mobility of 200 hip joints was studied in 100 persons aged 50–70 without any earlier diagnosis of the osteoarthritis of hip joints. We found that the most frequent limited movements on hip joints were: internal rotation of 25° or less (in 44% of cases) and “four test” 25 cm or more (in 33% of cases). Basing on these findings we propose a simple Index of the Limitation of Hip Joint mobility (ILHJ) – ratio: internal rotation (in grades)/“four test” (in cm). Degenerative changes are suspected when the value of the index is less than 1. The mobility limitation of the hip joint defined by ILHJ was more frequent (44%) in men than in women (25%), in the older group of 66–70 (42%) than in the younger one of 50–55 (17%) as well as in the group with pain typical of the osteoarthritis of the hip joint (inguinal region, femur and knee) (39%) than in the group without these complaints (15%). The proposed examination of mobility of hip joints is easy and takes less than half a minute. It might be recommended to family doctors. This kind of examination performed in all elderly patients can help early detection and treatment of osteoarthritis in hip joints.
REFERENCES (20)
1.
Croft P, Cooper C, Wickham C, et al. Defining osteoarthritis of the hip for the epidemiologic studies. Am J Epidemiol 1990; 132: 514-522.  .
 
2.
D’Ambrosia RD. Epidemiology of osteoarthritis. Orthopedics 2005; 28: 201-205.  .
 
3.
Nevitt MC. Definition of hip osteoarthritis for epidemiological studies. Ann Rheum Dis 1996; 55: 652-655.  .
 
4.
Solomon L. Clinical Features of Osteoarthritis. In: Oxford Textbook of Rheumatology, Maddison PJ, et al. (eds). Oxford 2001; 1409-1417.  .
 
5.
Szczepański L. Choroba zwyrodnieniowa stawów. W: Reumatologia kliniczna, Zimmermann-Górska I. (red.). Wydawnictwo Lekarskie PZWL, Warszawa 2008; 765-786.  .
 
6.
Doherty M, Jones A, Cawstone TE. Osteoarthritis. In: Kelley Textbook of Rheumatology, 6 ed. Saunders Co, Philadelphia 1999; 1515-1553  .
 
7.
Cibulka MT, White DM, Woehrle J, et al. Hip pain and mobility deficits – hip osteoarthritis: clinical practice guidelines linked to the International Classification of Functioning, Disability, and Health from the Orthopedic Section of the American Physical Therapy Association. J Orthop Sports Phys Ther 2009; 39: A1-25.  .
 
8.
Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations to the management of knee osteoarthritis: Report of a Task Force of Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003; 62: 1145-1155.  .
 
9.
Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000; 59: 936-944. .
 
10.
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000; 43: 1905-1915. .
 
11.
Brandt KD. The Role of Analgesics in the Management of Osteoarthritis Pain. Am J Ther 2000; 7: 75-90. .
 
12.
Hochberg MC, Altman RD, Brandt KD. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the Hip. American College of Rheumatology. Arthritis Rheum 1995; 38: 1535-1540. .
 
13.
Klimiuk PA, Sierakowski S, Kita K i wsp. Leczenie choroby zwyrodnieniowej stawów. Nowa Medycyna 2002; 9: 37-43. .
 
14.
Pelletier J-P, Martel-Pelletier J. Therapeutic targets in osteoarthritis: from today to tomorrow with new imaging technology. Ann Rheum Dis 2003; 62: 79-82. .
 
15.
Towheed TE. Current Status of Glucosamine Therapy in Osteoarthritis. Arthritis Rheum 2003; 49: 601-604. .
 
16.
McAlindon TE, LaValley MP, Gulin JP, et al. Glucosamine and chondroitin for the treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000; 283: 1469-1475. .
 
17.
Lievense AM, Bierma-Zeinstra SM, Verghagen AP, et al. Influense of obesity on the development of osteoarthritis of the hip. A systematic review. Rheumatology (Oxford) 2002; 41: 1155-1162. .
 
18.
Roddy E, Ahang W, Doherty M, et al. Evidence based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee – the MOVE consensus. Rheumatology (Oxford) 2005; 44: 67-73. .
 
19.
Oostendorp RA, vanden Heuevel JH, Dekker J, et al. Exercise therapy in patients with osteoarthritis of hip and knee: a protocol. Amers-foort/Utrecht. The Netherlands. NPI/NIVEL; 1998. .
 
20.
O’Connor MI. Sex differences in osteoarthritis of the hip and knee. J Am Acad Orthop Surg 2007; 15 (suppl 1): 522-525.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top